Gliomas are malignant tumors that arise from glial cells that support and protect neurons in the central nervous system. These tumors can develop anywhere in the brain or spinal cord and have a variety of morphologies and grades of malignancy, including forms such as astrocytomas, oligodendrogliomas, and anaplastic gliomas. Classification of gliomas is based on various criteria, including cell type, grade, and genetic characteristics. The difficulty of diagnosis, the variety of clinical manifestations, and the limited treatment options make gliomas a serious problem in neuroscience and oncology.
History of the disease and interesting historical facts
The history of glioma research dates back to the 19th century, when the first attempts to classify brain tumors were made. In 1926, scientist Harvey Cushing presented one of the first systems for classifying brain tumors, which included gliomas. In 1979, significant progress was made in understanding gliomas by identifying their genetic characteristics and molecular features. In recent decades, intensive research has been conducted to improve diagnostics and treatment methods, such as targeted therapy and immunotherapy. For example, one recent study showed that mutations in the IDH1 and TP53 genes are key to the pathogenesis of gliomas.
Epidemiology
Gliomas occupy a significant place among all malignant tumors of the central nervous system. According to statistics, gliomas account for about 30% of all brain tumors and 80% of all malignant tumors. The most common types of gliomas are astrocytomas, which occur in adults, while oligodendrogliomas are more common among the younger population. The incidence of gliomas varies depending on the geographic region, gender, and age: men are more susceptible to this disease than women. The age group of 20-40 years has the highest number of cases, but cases of gliomas are also registered among the elderly.
Genetic predisposition to this disease
Genetic predisposing factors for the development of gliomas include mutations in specific genes. Among the most studied are the IDH1 and IDH2 genes, which are involved in cell metabolism. Mutations in these genes lead to the formation of 2-hydroxyglutarate, which disrupts cellular metabolism and promotes carcinogenesis. Other genes involved include TP53, which is responsible for apoptosis, and ATRX, which is important in maintaining genomic stability. Mutations in the NF1 and EGFR genes have also been identified in some patients, indicating that genetic predisposition to gliomas is multifactorial.
Risk factors for the development of this disease
There are various risk factors that contribute to the development of gliomas, including:
- Physical factors:
- Ionizing radiation, such as that received during treatment of other tumors.
- Having a family history of malignant tumors.
- Chemical factors:
- Exposure to certain chemicals such as formaldehyde and styrene.
- Smoking, which can increase the risk of developing some types of gliomas.
- Other factors:
- Immunodeficiency, which leads to an increased likelihood of developing tumors.
- Some viral infections, such as Epstein-Barr virus.
Diagnosis of this disease
Diagnosis of gliomas requires a comprehensive approach and begins with a clinical assessment, where the main symptoms are:
- Headaches that may be constant or occur intermittently.
- Visual and hearing impairments.
- Convulsions that occur in many patients.
- Changes in behavior and cognitive function.
Laboratory tests are generally not specific for gliomas, but changes may be observed at the biochemical level. The main imaging methods are magnetic resonance imaging (MRI) and computed tomography (CT), which allow detailed visualization of the tumor and assessment of its prevalence. In some cases, a biopsy may also be indicated to determine the histological type of the tumor. Differential diagnosis includes distinguishing gliomas from other brain tumors, benign processes, and neurological diseases.
Treatment
Treatment of gliomas can be divided into several main areas:
- General treatment:
- Surgical intervention is aimed at maximum removal of the tumor and improving the patient's quality of life.
- Radiation therapy is used to kill any remaining cancer cells.
- Pharmacological treatment:
- Chemotherapy using drugs such as temozolomide is the standard for many types of gliomas.
- Targeted therapy may also be used depending on the specific mutations.
- Other types of treatment:
- Immuno-oncological drugs and clinical trials of the latest methods of therapy.
- Supportive therapy to improve quality of life and reduce symptoms.
List of medications used to treat this disease
Among the drugs used to treat gliomas, the following can be distinguished:
- Temozolomide
- Sarcolysin
- Lomastine
- Methylprednisolone
- Everolimus
Disease monitoring
Monitoring patients with gliomas requires a multi-level approach. Key stages of monitoring are regular clinical examinations, as well as MRI to assess disease progression. The prognosis of gliomas varies depending on the tumor type, its location and the degree of malignancy. Complications in the form of relapse, metastasis and neurological disorders require special attention and support.
Age-related features of the disease
Gliomas can occur in different age groups, but their behavior and progression can vary significantly:
- In children, gliomas generally have a better prognosis than in adults.
- In older people, the development of gliomas is often associated with other diseases, which can complicate diagnosis and choice of treatment method.
- The average age of a patient with gliomas ranges from 30 to 60 years, although tumors can occur at an earlier age.
Questions and Answers
- What are the main symptoms of glioma? Major symptoms include headaches, seizures, visual disturbances and cognitive function.
- How is glioma diagnosed? Diagnostics include MRI, CT and biopsy to determine the histological type of the tumor.
- What is the likelihood of relapse after treatment? The likelihood of recurrence depends on the type of glioma and its stage, but can reach 50% for highly malignant forms.
- Are there risk factors for glioma? Yes, risk factors include ionizing radiation, chemicals and hereditary predisposition.
- What is the role of genetic mutations in the pathogenesis of gliomas? Mutations in genes such as IDH1 and TP53 play a key role in the development of gliomas, influencing carcinogenesis.
Advice from Dr. Oleg Korzhikov
The situation with gliomas requires special attention to one's own health and early diagnostics. Dr. Oleg Korzhikov advises:
- Undergo regular medical examinations, especially if you have a predisposition to diseases of the nervous system.
- If the first symptoms appear, such as frequent headaches or personality changes, contact a specialist in a timely manner.
- Explore new treatments and don't be afraid to take part in clinical trials, as this may provide access to new drugs and treatments.
- Maintaining a healthy lifestyle, including eating well and being physically active, can also help improve overall health.
In conclusion, it is important to remember that early diagnosis and comprehensive treatment play a crucial role in the fight against gliomas.
